海外の免疫療法専門医 — ページ3

この医師は、乳がん、肺がん、消化器系がんの治療を専門とする腫瘍学者です。現在、医師はIstinye Liv University Hospitalで診療を行っています。<\/p>

多くの著名な機関でのキャリアを持ち、医師はMalatya State Hospitalで内科専門医として、Ankara Oncology Clinicで医師として、Erzurum Regional Training and Research Hospitalの腫瘍学部門のメンバーとして勤務してきました。<\/p>

医師はSelcuk Universityの医学部を卒業し、2016年に准教授の称号を取得しました。<\/p>

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Tarik Salman is a clinical oncologist at Medicalpoint International Hospital in İzmir. He specializes in precise cancer treatments, including immunotherapy and comprehensive genomic profiling. Dr. Salman completed an observership at Memorial Sloan Kettering Cancer Center in New York. He is a former board member of the Turkish Society of Medical Oncology.

• Member of the European Society of Medical Oncology and American Society of Clinical Oncology.
• Treats lung, breast, and colon cancers using targeted therapies and cancer vaccines.
• Served as an academic visitor at the Moffitt Cancer Center in Florida.
• Holds board positions in geriatric and Mediterranean oncology associations.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.

• Principal Investigator in over 20 Phase II–III clinical trials.
• Participated as a sub-investigator in more than 50 international trials.
• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Founder of the La Vida en Rosa Foundation for women with cancer.

Radiotherapy Specialist, Oncologist

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Specialization and Clinical Focus

Prof. Ben Arush treats childhood cancers using therapeutic techniques. Her clinical work revolves around bone marrow transplantation and pediatric hematology. She treats a variety of conditions, including:

• Sarcoma and Ewing's sarcoma
• Neuroblastoma and Nephroblastoma (Wilms tumor)
• Osteosarcoma and Rhabdomyosarcoma
• Retinoblastoma

The doctor performs procedures such as chemotherapy, immunotherapy, and radiotherapy. She also provides targeted leukemia chemotherapy and radiation for specific solid tumors.

Professional Leadership and Experience

Prof. Ben Arush leads the Department of Pediatric Hematology and Oncology at Rambam Medical Center. She also oversees pediatric care at the Ruth Rappaport Children’s Hospital in Haifa. This role involves supervising oncological treatment for young patients in Israel.

Awards and Recognition

Prof. Ben Arush received international and national honors for her work. These awards include:

• Ministry of Health Prize for outstanding medical work
• Chevalier de la Legion d’Honneur (Knight of the Legion of Honour), France
• World Medical Association Caring Physicians of the World Award

Professional Memberships

The specialist participates in the global oncology research community. Her memberships include:

• Children’s Oncology Group (USA)
• Various European cancer societies

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Chief Physician of the Oncology Center, Oncologist

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

彼女の主な研究の関心は、血管新生、DNA修復メカニズム、免疫学にあり、卵巣癌、子宮頸癌、子宮内膜癌の臨床試験のいくつかのシリーズで主任研究者を務めています。

彼女は婦人科腫瘍に関する多数のプロジェクトを主導し、関与しています。彼女は様々な会議で100以上の出版物とプレゼンテーションの著者です。

育成

• 1994年にマドリードコンプルテンセ大学で医学および外科学の学位を取得。
   
• マドリードコンプルテンセ大学にある「プリンセサ大学病院」で医学腫瘍学 (MD) に特化。
   
• バルセロナ自治大学で博士号を取得。

実績

• GEICOグループ（スペイン卵巣癌研究グループ）の共同議長としての執行委員会メンバー。
   
• ヨーロッパ医学腫瘍学会（ESMO）での婦人科トラックの教員であり、GOGのスペイン代表。
   
• GEICO代表としてGCIGグループの子宮頸部委員会およびフェーズII委員会のスペイン代表。
   
• アメリカ臨床腫瘍学会（ASCO）、ヨーロッパ医学腫瘍学会（ESMO）、スペイン医学腫瘍学会（SEOM）の積極的なメンバー。